Skip to main content
Presentation
SAT0448 APREMILAST TREATMENT AND LONG-TERM (UP TO 156 WEEKS) IMPROVEMENTS IN DACTYLITIS AND ENTHESITIS IN PATIENTS WITH PSORIATIC ARTHRITIS: ANALYSIS OF A LARGE DATABASE OF THE PHASE III CLINICAL DEVELOPMENT PROGRAM. The European League against Rheumatism (EULAR) Annual European Congress of Rheumatology, Madrid, June 2017.
The European League against Rheumatism (EULAR) Annual European Congress of Rheumatology (2017)
  • DD Gladman
  • A Kavanaugh
  • Philip Mease, Providence St. Joseph Health
  • et.al.
Disciplines
Publication Date
June, 2017
Citation Information
DD Gladman, A Kavanaugh, Philip Mease and et.al.. "SAT0448 APREMILAST TREATMENT AND LONG-TERM (UP TO 156 WEEKS) IMPROVEMENTS IN DACTYLITIS AND ENTHESITIS IN PATIENTS WITH PSORIATIC ARTHRITIS: ANALYSIS OF A LARGE DATABASE OF THE PHASE III CLINICAL DEVELOPMENT PROGRAM. The European League against Rheumatism (EULAR) Annual European Congress of Rheumatology, Madrid, June 2017." The European League against Rheumatism (EULAR) Annual European Congress of Rheumatology (2017)
Available at: http://works.bepress.com/philip-mease/249/